Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Multiple system atrophy--update].

Hidenao Sasaki1

  • 1Department of Neurology, Division of Neurological Science, Hokkaido University Graduate School of Medicine.

Rinsho Shinkeigaku = Clinical Neurology
|January 18, 2005
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Suspected Postpartum Depression Revealed to be CSF1R-Related Leukoencephalopathy: A Case Report.

Case reports in neurology·2024
Same author

Dynamic molecular network analysis of iPSC-Purkinje cells differentiation delineates roles of ISG15 in SCA1 at the earliest stage.

Communications biology·2024
Same author

The Movement Disorder Society Criteria: Its Clinical Usefulness in Multiple System Atrophy.

Internal medicine (Tokyo, Japan)·2024
Same author

Genome-wide association study identifies a new susceptibility locus in <i>PLA2G4C</i> for Multiple System Atrophy.

medRxiv : the preprint server for health sciences·2023
Same author

High-dose ubiquinol supplementation in multiple-system atrophy: a multicentre, randomised, double-blinded, placebo-controlled phase 2 trial.

EClinicalMedicine·2023
Same author

[Spinocerebellar Degeneration: One Liter of Tears].

Brain and nerve = Shinkei kenkyu no shinpo·2022

Multiple system atrophy (MSA) is a neurodegenerative disorder characterized by autonomic failure, cerebellar ataxia, and parkinsonism. Diagnosis relies on clinical criteria and neuroimaging, aiding future preventive measures.

Area of Science:

  • Neuroscience and Neurology
  • Pathology and Genetics

Context:

  • Multiple system atrophy (MSA) is an adult-onset neurodegenerative disorder.
  • It presents with progressive autonomic failure, cerebellar ataxia, and parkinsonism.
  • MSA constitutes over 40% of spinocerebellar ataxias in Japan.

Purpose:

  • To outline the pathological hallmarks of MSA, including myelinopathy, neuronal loss, gliosis, and alpha-synuclein accumulation.
  • To review current diagnostic criteria (Quinn's, Consensus Criteria, Japanese criteria) and their contribution to MSA research.
  • To highlight the role of various clinical manifestations and neuroimaging techniques (MRI, SPECT) in differential diagnosis.

Summary:

  • Pathologically, MSA is defined by myelinopathy, neuronal loss, gliosis, and alpha-synuclein accumulation, primarily in oligodendroglia.

Related Experiment Videos

  • Clinical diagnosis utilizes established criteria and considers additional symptoms like dystonia, myoclonus, and sleep disturbances.
  • Neuroimaging, including MRI and SPECT for dopamine transporter and D2 receptor imaging, enhances diagnostic accuracy.

    • Impact:

    • Improved diagnostic reliability through comprehensive clinical and neuroimaging assessments.
    • Foundation for future research into the unknown mechanisms causing MSA.
    • Informs the development of preventive strategies once the disorder's etiology is understood.